Belvedere Trading LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Belvedere Trading LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 30, 2024	SELL	$23.91 - $31.3 $413,643 - $541,490	-17,300 Reduced 55.45%	13,900 $353,000
Q2 2024 Nov 01, 2024	BUY	$23.0 - $31.04 $397,900 - $536,992	17,300 Added 124.46%	31,200 $790,000
Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $501,400 - $676,672	21,800 Added 231.91%	31,200 $790,000
Q1 2024 May 09, 2024	SELL	$27.35 - $40.45 $232,475 - $343,825	-8,500 Reduced 47.49%	9,400 $290,000
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $62,452 - $114,114	2,600 Added 16.99%	17,900 $722,000
Q3 2023 Oct 27, 2023	SELL	$16.89 - $35.01 $346,245 - $717,705	-20,500 Reduced 57.26%	15,300 $403,000
Q2 2023 Aug 08, 2023	BUY	$13.29 - $18.01 $65,120 - $88,249	4,900 Added 15.86%	35,800 $615,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $221,553 - $573,195	30,900 New	30,900 $512,000
Q2 2022 Jul 21, 2022	BUY	$5.21 - $12.14 $43,243 - $100,762	8,300 New	8,300 $80,000
Q1 2022 Apr 20, 2022	SELL	$7.34 - $17.16 $111,568 - $260,832	-15,200 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$11.38 - $53.41 $172,976 - $811,832	15,200 New	15,200 $157,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.